Related Experiment Video
Updated: Jan 13, 2026

Experimental Model to Evaluate Resolution of Pneumonia
Published on: February 17, 2023
Artificial intelligence model outperformed experienced clinicians in differentiating the aetiology of pneumonia on
Wenting Jin1, Ying Shao2, Jue Pan1
1Department of Infectious Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.
Background:
Rapid and precise aetiological diagnosis is crucial for managing pneumonia. We aimed to develop and validate deep learning (DL) models for differentiating ten pneumonia aetiologies on chest computed tomography images.
Methods:
We enrolled 1,091 pneumonia patients with 1 of 10 definite aetiological diagnoses between October 1st, 2015 and June 30th, 2022 in this retrospective study. We trained and validated two DL models: a classic 3D-DenseNet model (DenseNet) and a novel large vision model (LVM). The models were tested on a data from 183 nonoverlapping patients for external dataset. Model performance was assessed using the area under the curve (AUC) of the Top1 diagnosis and the accuracy of the Top1, Top2, and Top3 diagnoses. Comparisons were also performed between the DL models and eight experienced radiologists and pulmonologists.
Results:
The LVM combined with non-imaging model (LVM+) had a greater average prediction performance than DenseNet combined with non-imaging model (DenseNet+), radiologists' results with non-imaging data (radiologists+) and pulmonologists' results with non-imaging data (pulmonologists+), with Top1 AUCs of 0.872, 0.851, 0.643 and 0.644, respectively. The Top1, Top2, and Top3 accuracies of LVM+ were 0.527, 0.701 and 0.820, respectively, similarly outperforming DenseNet+, radiologists+ and pulmonologists+. The two models performed similarly in the external test sets, with the Top1 AUCs of 0.743 for DenseNet and 0.775 for LVM. The classification-related confusion matrix of LVM/DenseNet with or without non-imaging model showed a significant advantage in identifying pulmonary non-tuberculous mycobacterium pulmonary disease (PNTM), pulmonary tuberculosis (PTB) and Pneumocystis jirovecii pneumonia (PJP).
Conclusions:
This study presents a comprehensive classification closely aligned with pneumonia diagnosis in realistic clinical settings. We expect this method to be applied clinically to foster novel approaches to improve the accuracy in diagnosing pneumonia.
More Related Videos
06:22Machine Learning-Based Cough Tone Classification: Diagnostic Exploration of Chronic Obstructive Pulmonary Disease and Respiratory Tract Infections
Published on: September 19, 2025
08:05Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Related Concept Videos
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History